BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mantovani G, Madeddu C. Cancer cachexia: medical management. Support Care Cancer. 2010;18:1-9. [PMID: 19688225 DOI: 10.1007/s00520-009-0722-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Mondello P, Mian M, Aloisi C, Famà F, Mondello S, Pitini V. Cancer Cachexia Syndrome: Pathogenesis, Diagnosis, and New Therapeutic Options. Nutrition and Cancer 2014;67:12-26. [DOI: 10.1080/01635581.2015.976318] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
2 Mehrzad V, Afshar R, Akbari M. Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial. Adv Biomed Res 2016;5:60. [PMID: 27135029 DOI: 10.4103/2277-9175.179182] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gullett NP, Mazurak VC, Hebbar G, Ziegler TR. Nutritional interventions for cancer-induced cachexia. Curr Probl Cancer 2011;35:58-90. [PMID: 21420558 DOI: 10.1016/j.currproblcancer.2011.01.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 6.6] [Reference Citation Analysis]
4 Lavriv DS, Neves PM, Ravasco P. Should omega-3 fatty acids be used for adjuvant treatment of cancer cachexia? Clin Nutr ESPEN 2018;25:18-25. [PMID: 29779814 DOI: 10.1016/j.clnesp.2018.02.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
5 Blum RA, Mair S, Duus EM. Appetite and food intake results from phase I studies of anamorelin. J Cachexia Sarcopenia Muscle 2019;10:1027-35. [PMID: 31074178 DOI: 10.1002/jcsm.12439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Baba MR, Buch SA. Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches. Asia Pac J Oncol Nurs 2021;8:508-18. [PMID: 34527780 DOI: 10.4103/apjon.apjon-2126] [Reference Citation Analysis]
7 Nicolini A, Ferrari P, Masoni MC, Fini M, Pagani S, Giampietro O, Carpi A. Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment. Biomedicine & Pharmacotherapy 2013;67:807-17. [DOI: 10.1016/j.biopha.2013.08.005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
8 Häne H, Oberholzer R, Walker J, Hopkinson JB, de Wolf-Linder S, Strasser F. Psychosocial consequences of cancer cachexia: the development of an item bank. J Pain Symptom Manage 2013;46:795-806. [PMID: 23602324 DOI: 10.1016/j.jpainsymman.2013.01.008] [Reference Citation Analysis]
9 Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Sanna E, Cau MC, Panzone F, Mantovani G. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol. 2012;124:417-425. [PMID: 22198049 DOI: 10.1016/j.ygyno.2011.12.435] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.1] [Reference Citation Analysis]
10 Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, Buonaccorso L, de van der Schueren MAE, Baldwin C, Chasen M, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO Open 2021;6:100092. [PMID: 34144781 DOI: 10.1016/j.esmoop.2021.100092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
11 Cooper C, Burden ST, Cheng H, Molassiotis A. Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopenia Muscle 2015;6:99-111. [PMID: 26136417 DOI: 10.1002/jcsm.12010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
12 . Current world literature. Curr Opin Support Palliat Care 2011;5:65-8. [PMID: 21321522 DOI: 10.1097/SPC.0b013e3283440ea5] [Reference Citation Analysis]
13 Currow DC, Maddocks M, Cella D, Muscaritoli M. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion. Int J Mol Sci 2018;19:E3471. [PMID: 30400622 DOI: 10.3390/ijms19113471] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
14 Payne C, Wiffen PJ, Martin S. WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database Syst Rev 2017;4:CD008427. [PMID: 28387447 DOI: 10.1002/14651858.CD008427.pub3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Cooper C, Burden ST, Molassiotis A. An explorative study of the views and experiences of food and weight loss in patients with operable pancreatic cancer perioperatively and following surgical intervention. Support Care Cancer 2015;23:1025-33. [PMID: 25277960 DOI: 10.1007/s00520-014-2455-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
16 Li W, Swiderski K, Murphy KT, Lynch GS. Role for Plant-Derived Antioxidants in Attenuating Cancer Cachexia. Antioxidants 2022;11:183. [DOI: 10.3390/antiox11020183] [Reference Citation Analysis]
17 Kanat O, Cubukcu E, Avci N, Budak F, Ercan I, Canhoroz M, Olmez F. Comparison of Three Different Treatment Modalities in the Management of Cancer Cachexia. Tumori 2013;99:229-33. [DOI: 10.1177/030089161309900218] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
18 Virizuela JA, Camblor-Álvarez M, Luengo-Pérez LM, Grande E, Álvarez-Hernández J, Sendrós-Madroño MJ, Jiménez-Fonseca P, Cervera-Peris M, Ocón-Bretón MJ. Nutritional support and parenteral nutrition in cancer patients: an expert consensus report. Clin Transl Oncol 2018;20:619-29. [PMID: 29043569 DOI: 10.1007/s12094-017-1757-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
19 Ábrigo J, Elorza AA, Riedel CA, Vilos C, Simon F, Cabrera D, Estrada L, Cabello-Verrugio C. Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia. Oxid Med Cell Longev 2018;2018:2063179. [PMID: 29785242 DOI: 10.1155/2018/2063179] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 18.8] [Reference Citation Analysis]
20 Kim AJ, Hong DS, George GC. Diet-related interventions for cancer-associated cachexia. J Cancer Res Clin Oncol 2021;147:1443-50. [PMID: 33718995 DOI: 10.1007/s00432-021-03592-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Holm T, Maier A, Wicks P, Lang D, Linke P, Münch C, Steinfurth L, Meyer R, Meyer T. Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study. Interact J Med Res 2013;2:e8. [PMID: 23608722 DOI: 10.2196/ijmr.2463] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
22 Foletta VC, White LJ, Larsen AE, Léger B, Russell AP. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch - Eur J Physiol 2011;461:325-35. [DOI: 10.1007/s00424-010-0919-9] [Cited by in Crossref: 195] [Cited by in F6Publishing: 187] [Article Influence: 17.7] [Reference Citation Analysis]
23 Reuter SE, Martin JH. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. Clin Pharmacokinet 2016;55:807-12. [DOI: 10.1007/s40262-015-0363-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
24 Bresciani E, Rizzi L, Molteni L, Ravelli M, Liantonio A, Ben Haj Salah K, Fehrentz J, Martinez J, Omeljaniuk RJ, Biagini G, Locatelli V, Torsello A. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia. Endocrine 2017;58:106-14. [DOI: 10.1007/s12020-016-1184-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
25 Baldwin C. Nutritional support for malnourished patients with cancer. Current Opinion in Supportive & Palliative Care 2011;5:29-36. [DOI: 10.1097/spc.0b013e328343a05d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
26 Mori T, Ohmori H, Luo Y, Mori S, Miyagawa Y, Nukaga S, Goto K, Fujiwara-Tani R, Kishi S, Sasaki T, Fujii K, Kawahara I, Kuniyasu H. Giving combined medium-chain fatty acids and glucose protects against cancer-associated skeletal muscle atrophy. Cancer Sci 2019;110:3391-9. [PMID: 31432554 DOI: 10.1111/cas.14170] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Payne C, Wiffen PJ, Martin S. Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database Syst Rev 2012;1:CD008427. [PMID: 22258985 DOI: 10.1002/14651858.CD008427.pub2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
28 Gorjao R, Dos Santos CMM, Serdan TDA, Diniz VLS, Alba-Loureiro TC, Cury-Boaventura MF, Hatanaka E, Levada-Pires AC, Sato FT, Pithon-Curi TC, Fernandes LC, Curi R, Hirabara SM. New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids. Pharmacol Ther 2019;196:117-34. [PMID: 30521881 DOI: 10.1016/j.pharmthera.2018.12.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
29 Schäfer M, Oeing CU, Rohm M, Baysal-Temel E, Lehmann LH, Bauer R, Volz HC, Boutros M, Sohn D, Sticht C, Gretz N, Eichelbaum K, Werner T, Hirt MN, Eschenhagen T, Müller-Decker K, Strobel O, Hackert T, Krijgsveld J, Katus HA, Berriel Diaz M, Backs J, Herzig S. Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia. Mol Metab 2016;5:67-78. [PMID: 26909315 DOI: 10.1016/j.molmet.2015.11.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
30 Tzika AA, Fontes-Oliveira CC, Shestov AA, Constantinou C, Psychogios N, Righi V, Mintzopoulos D, Busquets S, Lopez-Soriano FJ, Milot S, Lepine F, Mindrinos MN, Rahme LG, Argiles JM. Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model. Int J Oncol 2013;43:886-94. [PMID: 23817738 DOI: 10.3892/ijo.2013.1998] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 7.2] [Reference Citation Analysis]
31 Toneto AT, Ferreira Ramos LA, Salomão EM, Tomasin R, Aereas MA, Gomes-Marcondes MC. Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals. J Cachexia Sarcopenia Muscle 2016;7:577-86. [PMID: 27030817 DOI: 10.1002/jcsm.12100] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
32 Grassi L, Caruso R, Hammelef K, Nanni MG, Riba M. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry 2014;26:44-62. [PMID: 24716500 DOI: 10.3109/09540261.2013.842542] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
33 Tuca Rodríguez A, Calsina-berna A, González-barboteo J, Gómez-batiste Alentorn X. Caquexia en cáncer. Medicina Clínica 2010;135:568-72. [DOI: 10.1016/j.medcli.2010.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Bresciani E, Rizzi L, Coco S, Molteni L, Meanti R, Locatelli V, Torsello A. Growth Hormone Secretagogues and the Regulation of Calcium Signaling in Muscle. Int J Mol Sci 2019;20:E4361. [PMID: 31491959 DOI: 10.3390/ijms20184361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
35 Prommer EE. Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer. Cancer Control 2015;22:403-11. [PMID: 26678967 DOI: 10.1177/107327481502200406] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol 2015; 7(4): 17-29 [PMID: 25897346 DOI: 10.4251/wjgo.v7.i4.17] [Cited by in CrossRef: 185] [Cited by in F6Publishing: 161] [Article Influence: 26.4] [Reference Citation Analysis]
37 Garcia JM, Friend J, Allen S. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer. 2013;21:129-137. [PMID: 22699302 DOI: 10.1007/s00520-012-1500-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 10.3] [Reference Citation Analysis]
38 Coss CC, Bohl CE, Dalton JT. Cancer cachexia therapy: a key weapon in the fight against cancer. Curr Opin Clin Nutr Metab Care. 2011;14:268-273. [PMID: 21415732 DOI: 10.1097/MCO.0b013e3283455e21] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
39 Tuca A, Jimenez-Fonseca P, Gascón P. Clinical evaluation and optimal management of cancer cachexia. Crit Rev Oncol Hematol. 2013;88:625-636. [PMID: 23953794 DOI: 10.1016/j.critrevonc.2013.07.015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
40 Hegde M, Daimary UD, Girisa S, Kumar A, Kunnumakkara AB. Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia. Exp Biol Med (Maywood) 2022;:15353702221087962. [PMID: 35521962 DOI: 10.1177/15353702221087962] [Reference Citation Analysis]
41 Chen S, Xiao J. Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model. Tumor Biol 2014;35:323-32. [DOI: 10.1007/s13277-013-1043-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
42 (Sandy) Macleod AD, Vella-brincat JWA. Cachexia, depression, and sickness behaviour. Progress in Palliative Care 2013;20:163-8. [DOI: 10.1179/1743291x12y.0000000026] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Sirago G, Conte E, Fracasso F, Cormio A, Fehrentz JA, Martinez J, Musicco C, Camerino GM, Fonzino A, Rizzi L, Torsello A, Lezza AMS, Liantonio A, Cantatore P, Pesce V. Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia. Sci Rep 2017;7:13017. [PMID: 29026190 DOI: 10.1038/s41598-017-13504-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]